Financials

  • Market Capitalization 2.16 B
  • Employee 325
  • Founded 2006
  • CEO Pravin Dugel
  • Website www.ocutx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BZV0
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.55
Price to sales ratio
43.75

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1904
MLYS
Mineralys Therapeutics, Inc. - Common Stock
27.59 USD-2.78%-7.14%+15.05%-31.66%2.28 B USD
1919
ZLAB
Zai Lab Limited - American Depositary Shares
19.62 USD-4.25%+2.24%+11.67%-26.49%2.20 B USD
1961
ADMA
ADMA Biologics Inc - Common Stock
8.97 USD-1.21%-3.34%+8.60%-51.93%2.08 B USD
1963
MESO
Mesoblast Limited - American Depositary Shares
16.22 USD+5.05%+12.64%+16.77%+44.95%2.08 B USD

Frequently asked questions about Ocular Therapeutix, Inc. - Common Stock

What is the Ocular Therapeutix, Inc. - Common Stock stock price today?

The current price of Ocular Therapeutix, Inc. - Common Stock (OCUL) is 9.88. Over the past 24 hours, the stock has changed by -3.14%. Follow the OCUL chart for real-time price dynamics.

What is the stock ticker of Ocular Therapeutix, Inc. - Common Stock?

Ocular Therapeutix, Inc. - Common Stock trades under the ticker OCUL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Ocular Therapeutix, Inc. - Common Stock stock going up?

OCUL has changed by +0.82% over the last week, +10.51% over the last month, and -14.09% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Ocular Therapeutix, Inc. - Common Stock net income for the last quarter?

Ocular Therapeutix, Inc. - Common Stock reported net income of -88.61 M for the last quarter. The previous quarter showed -64.65 M, which means net income changed by -37.06%.

How many employees does Ocular Therapeutix, Inc. - Common Stock have?

As of the latest available data, Ocular Therapeutix, Inc. - Common Stock has 325 employees. Workforce size can provide additional context about the company's scale and operations.

What is Ocular Therapeutix, Inc. - Common Stock EBITDA?

Ocular Therapeutix, Inc. - Common Stock EBITDA is -92.06 M, and its EBITDA margin is -853.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Ocular Therapeutix, Inc. - Common Stock stock?

You can buy Ocular Therapeutix, Inc. - Common Stock (OCUL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Ocular Therapeutix, Inc. - Common Stock stock?

Investing in Ocular Therapeutix, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OCUL chart and related analysis on metatrader.com as part of your research.

News